FDA
-
-
-
-
-
-
-
VectivBio Reports Full Year 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
VectivBio Holding AG (VECT) Reports Positive Interim Clinical Data from STARS Nutrition
-
-
-
-
-
-
-
VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications
-
-
-
-
-
-
-
VectivBio Presents New Clinical Data Supporting Apraglutide for Treatment of Short Bowel Syndrome with Intestinal Failure (SBS-IF) Patients Who Have Renal Dysfunction at the 2022 American Society of P
-
-
-
-
-
-
-
VectivBio (VECT) Announces Successful Opening of US IND for Apraglutide for Acute Graft-Versus-Host Disease
-
-
-
-
-
-
-
VectivBio Announces Results of Extraordinary General Meeting
-
-
-
-
-
-
-
VectivBio Nominates Paul R. Carter and Murray W. Stewart for Election to its Board of Directors
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

